Radioisotope Life Sciences (RLS) and Sofie Biosciences are entering into a strategic partnership for RLS to distribute Sofie's radiopharmaceuticals.
RLS will manage all patient dose preparation and distribution for Sofie in select markets.
The partnership will allow Sofie to access new markets, according to the two firms.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
